BIO joins suit to halt Medicare’s GLOBE pilot — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- BIO joined two California-based biotech trade groups in filing a complaint Friday against the Trump administration’s pilot program.
- GLOBE is the demonstration aimed at aligning Medicare drug prices with prices charged in peer countries.
- U.S. District Court for the Northern District of California is the venue where the complaint was filed, with the plaintiffs asserting that GLOBE oversteps Medicare’s statutory authority.
- GLOBE is the model the plaintiffs want the court to halt.
- Centers for Medicare and Medicaid Services did not immediately respond to a request for comment.
Why it matters: The concrete change is legal: BIO and two California trade groups have put GLOBE before a federal court and seek to halt it. For CMS and Medicare, the three-group filing means the peer-country pricing demonstration now faces a statutory-authority challenge, while the agency has not responded.
Ask SkimNews
